BAKER BROS. ADVISORS LP – BioMarin Pharmaceutical Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$645.98M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 14.47M | $84.77 | 7.62M | |
| Q2 2022 | share | 0.00% | 0 shares | 43.97M | $82.87 | 7.62M | |
| Q1 2022 | share | 0.00% | 0 shares | -85.73M | $77.1 | 7.62M | |
| Q4 2021 | share | 0.00% | 0 shares | 84.28M | $89.08 | 7.62M | |
| Q3 2021 | share | Increase | +0.41% | 31.2K shares | -44.26M | $77.29 | 7.62M |
| Q2 2021 | share | 0.00% | 0 shares | 60.18M | $83.44 | 7.58M | |
| Q1 2021 | share | 0.00% | 0 shares | -92.43M | $75.51 | 7.58M | |
| Q4 2020 | share | 0.00% | 0 shares | 88.11M | $87.69 | 7.58M | |
| Q3 2020 | share | 0.00% | 0 shares | -358.67M | $76.08 | 7.58M | |
| Q2 2020 | share | 0.00% | 0 shares | 294.76M | $123.34 | 7.58M | |
| Q1 2020 | share | 0.00% | 0 shares | -380K | $84.5 | 7.58M | |
| Q4 2019 | share | 0.00% | 0 shares | 130.15M | $84.55 | 7.58M | |
| Q3 2019 | share | 0.00% | 0 shares | -138.50M | $67.4 | 7.58M | |
| Q2 2019 | share | 0.00% | 0 shares | -24.13M | $85.65 | 7.58M | |
| Q1 2019 | share | 0.00% | 0 shares | 27.92M | $88.83 | 7.58M | |
| Q4 2018 | share | Increase | +0.08% | 6.21K shares | -89.10M | $85.15 | 7.58M |
| Q3 2018 | share | 0.00% | 0 shares | 21.00M | $96.97 | 7.58M | |
| Q2 2018 | share | 0.00% | 0 shares | 99.56M | $94.2 | 7.58M | |
| Q1 2018 | share | 0.00% | 0 shares | -61.42M | $81.07 | 7.58M | |
| Q4 2017 | share | Increase | +28.40% | 1.67M shares | 126.54M | $89.17 | 7.58M |
| Q3 2017 | share | 0.00% | 0 shares | 13.28M | $93.07 | 5.90M | |
| Q2 2017 | share | Increase | +22.87% | 1.09M shares | 114.44M | $90.82 | 5.90M |
| Q1 2017 | share | 0.00% | 0 shares | 23.74M | $87.78 | 4.80M | |
| Q4 2016 | share | 0.00% | 0 shares | -46.52M | $82.84 | 4.80M | |
| Q3 2016 | share | 0.00% | 0 shares | 70.75M | $92.52 | 4.80M | |
| Q2 2016 | share | 0.00% | 0 shares | -22.49M | $77.8 | 4.80M | |
| Q1 2016 | share | Increase | +16.80% | 691.4K shares | -34.65M | $82.48 | 4.80M |